| scholarly article | Q13442814 |
| P50 | author | Timothy M. Uyeki | Q84362200 |
| Hongjie Yu | Q87745593 | ||
| Luzhao Feng | Q105045872 | ||
| Qiaohong Liao | Q114398634 | ||
| Zhibin Peng | Q127777696 | ||
| P2093 | author name string | Yu Wang | |
| Yuan Yuan | |||
| Hui Jiang | |||
| Lei Zhou | |||
| Yuelong Shu | |||
| Paul Gargiullo | |||
| Zijian Feng | |||
| Yanping Zhang | |||
| Cuiling Xu | |||
| Nijuan Xiang | |||
| Weizhong Yang | |||
| Min Ye | |||
| Yang Huai | |||
| Yingdong Zheng | |||
| Zhancheng Gao | |||
| Jiandong Zheng | |||
| Yunxia Feng | |||
| P2860 | cites work | Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 | Q28260987 |
| Critically Ill patients with 2009 influenza A(H1N1) in Mexico | Q28261205 | ||
| Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China | Q28749090 | ||
| Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California | Q29305524 | ||
| Prevalence and trends in obesity among US adults, 1999-2008 | Q29547759 | ||
| The global burden of typhoid fever | Q29619215 | ||
| Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza | Q30227298 | ||
| Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis | Q30227428 | ||
| H1N1 2009 influenza virus infection during pregnancy in the USA. | Q30379409 | ||
| Critical care services and 2009 H1N1 influenza in Australia and New Zealand. | Q30381497 | ||
| Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. | Q30382272 | ||
| Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. | Q30383431 | ||
| Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. | Q30383867 | ||
| Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. | Q30384722 | ||
| Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. | Q30387004 | ||
| Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States | Q30388312 | ||
| Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection | Q30388857 | ||
| Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. | Q30389702 | ||
| Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome | Q33474780 | ||
| Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study | Q33739547 | ||
| Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. | Q34994903 | ||
| Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women | Q35641291 | ||
| Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada | Q37055208 | ||
| Factors associated with early hospital discharge of adult influenza patients. | Q43176079 | ||
| Deaths from Asian influenza associated with pregnancy. | Q43210459 | ||
| Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. | Q45382753 | ||
| Critically ill patients with 2009 influenza A(H1N1) infection in Canada | Q50580869 | ||
| Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008 | Q56621069 | ||
| Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus | Q57109572 | ||
| Antiviral Treatment for Patients Hospitalized with Severe Influenza Infection May Affect Clinical Outcomes | Q59314248 | ||
| Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season | Q83152060 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | People's Republic of China | Q148 |
| pandemic | Q12184 | ||
| P304 | page(s) | 457-465 | |
| P577 | publication date | 2011-01-10 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China | |
| P478 | volume | 52 |
| Q36376234 | A Downward Trend of the Ratio of Influenza RNA Copy Number to Infectious Viral Titer in Hospitalized Influenza A-Infected Patients |
| Q91610063 | An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice |
| Q30372931 | An overview of the characteristics of the novel avian influenza A H7N9 virus in humans. |
| Q30210112 | Antivirals for influenza: where now for clinical practice and pandemic preparedness? |
| Q28260818 | Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies |
| Q37164250 | Association between obesity and vulnerability and serologic response to influenza vaccination in older adults |
| Q34783541 | Body mass index and risk of pneumonia: a systematic review and meta-analysis |
| Q38665457 | Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. |
| Q34968677 | CD206+ cell number differentiates influenza A (H1N1)pdm09 from seasonal influenza A virus in fatal cases. |
| Q49988058 | Candida auris: a Review of the Literature. |
| Q58861495 | Características de los pacientes ingresados por sospecha de gripe A (H1N1) según confirmación microbiológica |
| Q38678816 | Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient data. |
| Q30426962 | Characteristics of hospitalized cases with influenza A (H1N1)pdm09 infection during first winter season of post-pandemic in China |
| Q30373846 | Characterizing the epidemiology, virology, and clinical features of influenza in China's first severe acute respiratory infection sentinel surveillance system, February 2011-October 2013. |
| Q30224583 | Children with special health care needs and preparedness: experiences from seasonal influenza and the 2009 H1N1 influenza pandemic |
| Q64134362 | Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa |
| Q47323372 | Clinical and economic analysis of the 2009 H1N1 influenza pandemic among pregnant Korean women. |
| Q57799840 | Clinical characteristics of patients with laboratory-confirmed influenza A(H1N1)pdm09 during the 2013/2014 and 2015/2016 clade 6B/6B.1/6B.2-predominant outbreaks |
| Q30415511 | Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States |
| Q53516441 | Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. |
| Q43865089 | Editorial commentary. "Late" treatment with neuraminidase inhibitors for severely ill patients with influenza: better late than never? |
| Q30364202 | Effect of rapid influenza diagnostic testing on antiviral treatment decisions for patients with influenza-like illness: southwestern U.S., May-December 2009 |
| Q30419932 | Epidemiological analysis of critically ill adult patients with pandemic influenza A(H1N1) in South Korea |
| Q35111068 | Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza A H7N9 virus infection from Jiangsu Province, Eastern China |
| Q28729170 | Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico |
| Q34341070 | Epidemiology of human infections with avian influenza A(H7N9) virus in China. |
| Q30385450 | Epidemiology, Seasonality and Treatment of Hospitalized Adults and Adolescents with Influenza in Jingzhou, China, 2010-2012. |
| Q40079240 | Estimating influenza disease burden among pregnant women: Application of self-control method |
| Q30432453 | Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. |
| Q46241514 | Impact of Bariatric Surgical Intervention on Peripheral Blood Neutrophil (PBN) Function in Obesity |
| Q36549406 | Influence of obesity on clinical outcomes in hospitalized children: a systematic review |
| Q90699236 | Influenza A (H1N1) virus infection and TNF-308, IL6, and IL8 polymorphisms in Egyptian population: a case-control study |
| Q38304274 | Influenza treatment with oseltamivir outside of labeled recommendations |
| Q39371271 | Lack of association between body weight and mortality in patients on veno-venous extracorporeal membrane oxygenation |
| Q30151684 | Morbid Obesity in Disasters: Bringing the "Conspicuously Invisible" into Focus |
| Q35192751 | Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. |
| Q30392472 | Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data |
| Q30370599 | Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. |
| Q30416191 | Obesity and the risk and outcome of infection |
| Q90008053 | Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains |
| Q30424988 | Occurrence of AH1N1 viral infection and clinical features in symptomatic patients who received medical care during the 2009 influenza pandemic in Central Mexico |
| Q30407250 | Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary |
| Q38682985 | Overview of influenza vaccination policy in Beijing, China: Current status and future prospects |
| Q30414804 | Pandemic 2009 A(H1N1) infection requiring hospitalization of elderly Spanish adults |
| Q30432104 | Pandemic H1N1 illness prognosis: evidence from clinical and epidemiological data from the first pandemic wave in São Paulo, Brazil |
| Q30423554 | Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case-control study |
| Q57101305 | Pediatric hospitalizations with influenza A infection during the 2009-2010 pandemic in five hospitals in Japan |
| Q36924693 | Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers |
| Q41930550 | Possible explanations for why some countries were harder hit by the pandemic influenza virus in 2009 - a global mortality impact modeling study |
| Q30378136 | Post-pandemic influenza a (H1N1) 2009 virus infection in pregnant women in Ceará, Brazil. |
| Q41927260 | Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management. |
| Q30414153 | Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. |
| Q30363464 | Predictors of fatality in pandemic influenza A (H1N1) virus infection among adults. |
| Q30423100 | Pregnancy, obesity and other risk factors for complications in influenza A(H1N1) pdm09 infection |
| Q40286902 | Rapid Influenza Diagnostic Tests Improve Suitability of Antiviral Treatment in Hospitalized Children |
| Q30430391 | Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China |
| Q64107274 | Respiratory tract virus infections in the elderly with pneumonia |
| Q30358632 | Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital. |
| Q30224647 | Response to the first wave of pandemic (H1N1) 2009: experiences and lessons learnt from China |
| Q90560561 | Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China |
| Q30224744 | Review on the impact of pregnancy and obesity on influenza virus infection |
| Q30405404 | Risk factors for death from pandemic (H1N1) 2009, southern Brazil. |
| Q30404745 | Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis |
| Q30398670 | Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009-15. |
| Q45358129 | Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission. |
| Q30411253 | Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China |
| Q30388374 | Severe maternal morbidity due to respiratory disease and impact of 2009 H1N1 influenza A pandemic in Brazil: results from a national multicenter cross-sectional study |
| Q64137492 | Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014-2015 and 2015-2016 |
| Q30409273 | Severity of pandemic H1N1 2009 influenza virus infection may not be directly correlated with initial viral load in upper respiratory tract. |
| Q30414225 | Sociodemographic factors and clinical conditions associated to hospitalization in influenza A (H1N1) 2009 virus infected patients in Spain, 2009-2010. |
| Q92229164 | Spatiotemporal Analysis of Influenza in China, 2005-2018 |
| Q90148108 | Targeting Peroxisome Proliferator-Activated Receptor-Gamma Decreases Host Mortality After Influenza Infection in Obese Mice |
| Q36256314 | Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015). |
| Q40047799 | The Impact of Obesity and Timely Antiviral Administration on Severe Influenza Outcomes Among Hospitalized Adults. |
| Q95840903 | The Phylodynamics of Seasonal Influenza A/H1N1pdm Virus in China Between 2009 and 2019 |
| Q37259897 | The association between obesity and outpatient visits for acute respiratory infections in Ontario, Canada |
| Q34369010 | The comparative clinical course of pregnant and non-pregnant women hospitalised with influenza A(H1N1)pdm09 infection. |
| Q28088540 | The weight of obesity on the human immune response to vaccination |
| Q42257424 | Timely estimates of influenza A H7N9 infection severity |
| Q45974600 | Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. |
| Q30224656 | Two years after pandemic influenza A/2009/H1N1: what have we learned? |
| Q30249134 | Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis |
| Q26852219 | What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia? |
Search more.